Literature DB >> 2990354

X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred.

E J Androphy, I Dvoretzky, D R Lowy.   

Abstract

We describe a family with typical epidermodysplasia verruciformis (EV) in which only male members are affected. Whereas none of the index patient's ten children have EV, four of eight grandsons born to his daughters have inherited the disorder. All are infected with human papillomavirus (HPV) 3 and HPV 8. The inheritance in this kindred most likely results from an X-linked recessive genetic defect. Since other kindreds have been described with autosomal inheritance, this novel inheritance pattern suggests that the persistent high clinical susceptibility to HPV infection characteristic of EV may result from defects in either of at least two different genetic loci, one of which may be located on the X chromosome.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990354

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  14 in total

Review 1.  Mechanisms of human papillomavirus-induced oncogenesis.

Authors:  Karl Münger; Amy Baldwin; Kirsten M Edwards; Hiroyuki Hayakawa; Christine L Nguyen; Michael Owens; Miranda Grace; Kyungwon Huh
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Bilateral recurrent ocular surface squamous cell cancer associated with epidermodysplasia verruciformis.

Authors:  Tarun Arora; Sourabh Sharma; Namrata Sharma; Jeewan S Titiyal
Journal:  BMJ Case Rep       Date:  2015-01-30

Review 3.  Epidermodysplasia verruciformis in an HIV-infected man: a case report and review of the literature.

Authors:  Amit Kaushal; Shane Silver; Ken Kasper; Alberto Severini; Sate Hamza; Yoav Keynan
Journal:  Top Antivir Med       Date:  2012-12

Review 4.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

5.  Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.

Authors:  David F McDermott; Bryan Gammon; Peter J Snijders; Ihunanya Mbata; Beth Phifer; A Howland Hartley; Chyi-Chia Richard Lee; Philip M Murphy; Sam T Hwang
Journal:  Pediatr Dermatol       Date:  2009 May-Jun       Impact factor: 1.588

Review 6.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

Review 7.  Multiple metachronous skin squamous cell carcinomas and epidermodysplasia verruciformis in the head region: a human papilloma virus-associated disease.

Authors:  B P Weber; G Fierlbeck; H G Kempf
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

8.  Epidermodysplasia verruciformis: Langerhans cells, immunologic effect of retinoid treatment and cytogenetics.

Authors:  P C van Voorst Vader; M C de Jong; R Blanken; C G Kallenberg; A Vermey; J M Scheres
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

9.  Lewandowsky and lutz dysplasia: report of two cases in a family.

Authors:  Bhawna Bhutoria; Kaushik Shome; Sulekha Ghosh; Koushik Bose; Chhanda Datta; Subodh Bhattacharya
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

10.  Efficacy of oral zinc therapy in epidermodysplasia verruciformis with squamous cell carcinoma.

Authors:  Sudhanshu Sharma; Krishna Deb Barman; Rashmi Sarkar; Mukesh Manjhi; Vijay Kumar Garg
Journal:  Indian Dermatol Online J       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.